Cyclosporine modulation of multidrug resistance in combination with pravastatin, mitoxantrone and etoposide for adult patients with relapsed/refractory acute myeloid leukemia: a phase 1/2 study

Leuk Lymphoma. 2013 Nov;54(11):2534-6. doi: 10.3109/10428194.2013.777836. Epub 2013 Mar 27.
No abstract available

Publication types

  • Clinical Trial, Phase I
  • Clinical Trial, Phase II
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cyclosporine / adverse effects
  • Drug Resistance, Multiple*
  • Drug Resistance, Neoplasm*
  • Etoposide / administration & dosage
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Mitoxantrone / administration & dosage
  • Pravastatin / administration & dosage
  • Treatment Outcome

Substances

  • Etoposide
  • Cyclosporine
  • Mitoxantrone
  • Pravastatin